N-terminal splice variants of the type I PACAP receptor: isolation, characterization and ligand binding/selectivity determinants
about
Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptorFamily-B G-protein-coupled receptorsShould pharmacologists care about alternative splicing? IUPHAR Review 4The mouse VPAC2 receptor confers suprachiasmatic nuclei cellular rhythmicity and responsiveness to vasoactive intestinal polypeptide in vitroStimulation of the ERK pathway by GTP-loaded Rap1 requires the concomitant activation of Ras, protein kinase C, and protein kinase A in neuronal cellsHomology modeling and molecular docking of human pituitary adenylate cyclase‑activating polypeptide I receptor.The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsIdentification of the early VIP-regulated transcriptome and its associated, interactome in resting and activated murine CD4 T cells.Pituitary adenylate cyclase-activating polypeptide stimulates glucose production via the hepatic sympathetic innervation in rats.The hop cassette of the PAC1 receptor confers coupling to Ca2+ elevation required for pituitary adenylate cyclase-activating polypeptide-evoked neurosecretion.PAC1hop, null and hip receptors mediate differential signaling through cyclic AMP and calcium leading to splice variant-specific gene induction in neural cellsTargeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis.Characterisation of the mouse vasoactive intestinal peptide receptor type 2 gene, Vipr2, and identification of a polymorphic LINE-1-like sequence that confers altered promoter activity.STC1 induction by PACAP is mediated through cAMP and ERK1/2 but not PKA in cultured cortical neuronsPharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.Consequences of splice variation on Secretin family G protein-coupled receptor functionClass II G protein-coupled receptors and their ligands in neuronal function and protectionAlternative Splicing of the Pituitary Adenylate Cyclase-Activating Polypeptide Receptor PAC1: Mechanisms of Fine Tuning of Brain Activity.Alternative splicing of pre-mRNA in cancer: focus on G protein-coupled peptide hormone receptors.PACAP receptor pharmacology and agonist bias: analysis in primary neurons and glia from the trigeminal ganglia and transfected cellsPACAP38 and PACAP6-38 exert cytotoxic activity against human retinoblastoma Y79 cells.Receptors for NPY and PACAP differ in expression and activity during adipogenesis in the murine 3T3-L1 fibroblast cell lineExpression, binding, and signaling properties of CRF2(a) receptors endogenously expressed in human retinoblastoma Y79 cells: passage-dependent regulation of functional receptors.PACAP inhibits delayed rectifier potassium current via a cAMP/PKA transduction pathway: evidence for the involvement of I k in the anti-apoptotic action of PACAP.Expression of pituitary adenylate cyclase activating polypeptide type 1 receptor (PAC1R) in the ewe hypothalamus: distribution and colocalization with tyrosine hydroxylase-immunoreactive neurones.Identification, expression and functional characterization of M4L, a muscarinic acetylcholine M4 receptor splice variant.Pituitary adenylate cyclase-activating polypeptide receptors in the trigeminovascular system: implications for migraine.PACAP38 and PAC receptor blockade: a new target for headache?
P2860
Q24309176-8540B82F-45D8-4B7C-8140-943D901C666BQ24542556-9D3D56E9-F9A3-43B6-A04D-F94E46812F79Q27025761-6F1DC125-1F2D-4380-9710-5E1BEC7DD77BQ28204645-0D50DA85-A987-49A9-8C14-12BBE8126F7DQ28513370-FBCB45B5-AED6-4113-9156-D9EAAD1D37A1Q30365203-9B72A3CB-2025-4AD3-B409-5E3C1C663DEEQ30486707-9D277520-9322-422A-9D5D-434A16E83BC3Q33712853-18038130-5F33-4E88-B164-3A1446A914E8Q33930193-57EC6231-F0D3-4708-8BD4-12068B57DEF2Q34280490-7A5D6ED3-4F34-4F38-AEB3-7C9B73B601B8Q35184653-2DB256B0-AE25-4974-8BEE-4BA682145777Q35295564-FCF2C6B7-30D4-49E8-A4EA-E3FC81B66D9DQ35648983-859FD922-B70F-48A1-BC5B-0DA64F566D1EQ35667237-D0260EF4-B1E0-4264-9FC2-3F5071E7DCBFQ36153216-3275B411-A49A-4D5B-86BC-675DCA359A66Q36153242-F3C72B12-9A7F-4AD1-81BF-DE6A7651E373Q36211439-2104E239-1B82-4D60-9851-14406888C338Q36860090-59A67EBF-BC8D-4768-879A-257ECDE771A0Q37278402-268FD4B4-BFCC-4302-A0A6-81E940C9F1A3Q38274844-5F6C7268-CC2A-4764-908C-822495BB0B9AQ39025126-961AE2CB-8561-40AF-B313-2013C9F91E35Q39855464-566AD753-2170-4C87-ACE0-C094E676C1F8Q40058767-37808465-3ED3-4A0E-8E88-3CE8E5DE3295Q44831617-F95343C9-E93A-4E40-926D-6E8803A75895Q46470664-02200DCA-7EF5-4E88-A9B2-50407E4CF4C8Q47143907-2A2CC50B-2BBC-4A97-B344-939136DE39C3Q48034068-0753E02C-42A9-4869-A121-DCB3D2FEBA53Q58797905-05CA0FC1-DF8A-45FE-BEAD-D5824BE655D8
P2860
N-terminal splice variants of the type I PACAP receptor: isolation, characterization and ligand binding/selectivity determinants
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
N-terminal splice variants of ...... nding/selectivity determinants
@ast
N-terminal splice variants of ...... nding/selectivity determinants
@en
N-terminal splice variants of ...... nding/selectivity determinants
@nl
type
label
N-terminal splice variants of ...... nding/selectivity determinants
@ast
N-terminal splice variants of ...... nding/selectivity determinants
@en
N-terminal splice variants of ...... nding/selectivity determinants
@nl
prefLabel
N-terminal splice variants of ...... nding/selectivity determinants
@ast
N-terminal splice variants of ...... nding/selectivity determinants
@en
N-terminal splice variants of ...... nding/selectivity determinants
@nl
P2093
P2860
P1476
N-terminal splice variants of ...... nding/selectivity determinants
@en
P2093
F M Dautzenberg
G Mevenkamp
R L Hauger
P2860
P356
10.1046/J.1365-2826.1999.00411.X
P407
P577
1999-12-01T00:00:00Z